Financial Risk Analysis for Innovative Pharmaceutical Enterprises.

Can Tang,Yumin He,Ming Bai,Hong Fang
DOI: https://doi.org/10.1109/CISP-BMEI60920.2023.10373246
2023-01-01
Abstract:Innovative pharmaceutical enterprises face opportunities and challenges because the competition among innovative pharmaceutical enterprises is intensifying. This paper proposes a method to evaluate financial risk for innovative pharmaceutical enterprises. The financial risk of innovative pharmaceutical enterprises are evaluated in four aspects and by the Z-Score model. An application example of the proposed method is provided. The research provide an applicable method for innovative pharmaceutical enterprises to evaluate to control their financial risk so as to sustain competitive advantage.
What problem does this paper attempt to address?